Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,947 | 11,048 | 8,229 | 4,055 | 5,122 |
| TOTAL | $11,334 | $11,279 | $8,592 | $4,697 | $5,576 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 3 | 1 | 2 |
| Other Non-Current Assets | 44 | 58 | 71 | 84 | 97 |
| TOTAL | $46 | $60 | $74 | $85 | $99 |
| Total Assets | $11,380 | $11,339 | $8,666 | $4,782 | $5,675 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 526 | 303 | 1,837 | 1,317 | 1,297 |
| Accrued Expenses | 530 | 433 | 750 | 1,388 | 960 |
| TOTAL | $1,100 | $794 | $2,643 | $2,759 | $2,309 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 15 | 30 | 44 |
| TOTAL | $N/A | $N/A | $15 | $30 | $44 |
| Total Liabilities | $1,100 | $794 | $2,658 | $2,789 | $2,353 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,186 | 1,771 | 1,445 | 117 | 90 |
| Retained earnings | -55,337 | -53,694 | -51,696 | -49,037 | -45,678 |
| TOTAL | $10,280 | $10,545 | $6,008 | $1,993 | $3,322 |
| Total Liabilities And Equity | $11,380 | $11,339 | $8,666 | $4,782 | $5,675 |